Morbilidad de la enfermedad pulmonar obstructiva crónica en Colombia. Resultados del estudio sanepoc-2
dc.contributor.author | Kuzmar, Isaac | |
dc.contributor.author | Giraldo Ospina, Carlos Eduardo | |
dc.contributor.author | Acevedo Osorio, Germán Oved | |
dc.contributor.author | Rua Salas, Guido | |
dc.date.accessioned | 2018-06-22T14:30:51Z | |
dc.date.available | 2018-06-22T14:30:51Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Objetivo: relacionar las morbilidades de los pacientes pertenecientes al programa de EPOC de una institución de salud del municipio de Anserma, Caldas (Colombia). Material y Métodos: estudio descriptivo de 51 pacientes a quienes les fueron tomadas espirometrías exploratorias, los hallazgos fueron contrastados con las principales comorbilidades registradas en la Historia Clínica a través de estadística descriptiva e inferencial. Resultados: 50% presentaron al menos una comorbilidad registrada, principalmente la Hipertensión Arterial seguida de la Enfermedad Renal Crónica, se encontró un comportamiento asociado entre la clasificación GOLD y la presencia de síntomas con valores no estadísticamente significativos; no se encontró asociación estadísticamente significativa entre las comorbilidades y los valores espirométricos. Conclusiones: se hacen necesarias nuevas investigaciones que valoren de forma clara la causalidad en la población colombiana. | spa |
dc.description.abstract | Objective: to relate the morbidities of patients belonging to the COPD program of a health institution in Anserma, Caldas (Colombia). Material and Methods: a descriptive study was presented with a sample of 51 patients who underwent exploratory spirometry, the findings were contrasted with the main commodities reported by the patients or the Medical Record through descriptive and inferential statistics. Results: 50% of the evaluated population had at least one recorded comorbidity; the main morbidity found was Arterial Hypertension followed by Chronic Kidney Disease; an associated behavior was found between the GOLD classification and the presence of symptoms with non-statistically significant values; no statistically significant association was found between comorbidities and spirometric values. Conclusions: new research is needed that clearly values causality in the Colombian population. | eng |
dc.identifier.issn | 00146722 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12442/2126 | |
dc.language.iso | spa | spa |
dc.publisher | Secretaría de Ciencia y Tecnología de la Facultad de Ciencias Médicas de la Universidad Nacional de Córdoba | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.license | Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional | spa |
dc.source | Vol. 75, No.1 (2018) | spa |
dc.source | Revista de la Facultad de Ciencias Médicas | spa |
dc.source.uri | https://revistas.unc.edu.ar/index.php/med/article/view/16617 | spa |
dc.subject | EPOC | spa |
dc.subject | Morbilidades | spa |
dc.subject | Espirometría | spa |
dc.subject | Colombia | spa |
dc.subject | Síntomas | spa |
dc.subject | COPD | eng |
dc.subject | Morbidities | eng |
dc.subject | Spirometry | eng |
dc.subject | Symptoms | eng |
dc.title | Morbilidad de la enfermedad pulmonar obstructiva crónica en Colombia. Resultados del estudio sanepoc-2 | spa |
dc.title.alternative | Morbidity of chronic obstructive pulmonary disease in Colombia. Results of the study sanepoc-2 | eng |
dc.type | article | spa |
dcterms.references | Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2012, 187(4):347–365. | eng |
dcterms.references | Menezes Ana y cols. PROYECTO LATINOAMERICANO DE INVESTIGACIÓN EN OBSTRUCCIÓN PULMONAR. Libro oficial. Capítulo 1. www.platino-alat.org | eng |
dcterms.references | WORLD HEALTH STATISTICS2014. WORLD HEALTH ORGANIZATIONWHO Library Cataloguing-in-Publication Data. ISBN 978 92 4 069267 1 (PDF) | eng |
dcterms.references | AnaMBMenezes, Cesar G Victora, Rogelio Perez-Padilla and the PLATINO Team. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Medical Research Methodology 2004, 4:15 doi:10.1186/1471-2288-415 | eng |
dcterms.references | Buist Sonia McBurnie Mary Ann et al. International variation in the prevalence of COPD(The BOLD Study): a population-based prevalence studyLancet 2007; 370: 741–50 | eng |
dcterms.references | Araya Marcela et al. Calidad de las espirometrías en un estudio epidemiológico de terreno. Factores determinantes de la necesidad de repetir el examen en el estudio Platino-Chile. Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-1 | eng |
dcterms.references | Buist Sonia McBurnie Mary Ann et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study Lancet 2007; 370: 741–50 | eng |
dcterms.references | VestboJ.Anderson W. et al.Evaluation of COPD Longitudinallyto Identify Predictive SurrogateEnd-points (ECLIPSE).EurRespir J 2008; 31: 869–873DOI: 10.1183/09031936.00111707CopyrightERS Journals Ltd 2008 | eng |
dcterms.references | American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107– 1136 | eng |
dcterms.references | Caballero Andres et al. Prevalence of COPD in Five ColombianCities Situated at Low, Medium, andHigh Altitude (PREPOCOL Study)*.CHEST/133/2/ FEBRUARY, 2008 | eng |
dcterms.references | Noriane a. Sievi, oliver senn,thomas brack et al.Impact of comorbidities on physical activity in COPD. Respirology (2015) 20, 413–418 © 2015 Asian Pacific Society of Respirology | eng |
dcterms.references | Bartolome R. Celli, Claudia G. Cote, Jose M. Marin et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. n engl j med 350;10 www.nejm.org march 4, 2004 | eng |
dcterms.references | Irene Torres-Sánchez, Elisabeth Rodríguez-Alzueta, Irene Cabrera-Martos et al. Cognitive impairment in COPD: a systematic review. J Bras Pneumol. 2015;41(2):182-190. http://dx.doi.org/10.1590/S1806-37132015000004424 | eng |
dcterms.references | Fausto Aloísio Pedrosa Pimentaa, Maria Aparecida Camargos Bicalhob, Marco Aurélio Romano-Silva.Chronic diseases, cognition, functional decline, and the Charlson index in elderly people with dementia. REV ASSOC MED BRAS. 2013;59(4):326-334 | eng |
dcterms.references | Black-Shinn, Kinney GL, Wise AL, Regan EA, Make B y cols. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD. 2014 Sep;11(5):546-51. doi: 10.3109/15412555.2014.898029. Epub 2014 May 15. | eng |
dcterms.references | Craig P Hersh1, Barry J Make, David A Lynch, et al.Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. Hersh et al. BMC Pulmonary Medicine 2014, 14:164 http://www.biomedcentral.com/1471-2466/14/164 | eng |
dcterms.references | Irene Torres-Sánchez, Marie Carmen Valenza, Fernando Carrasco et al. Alteraciones endocrinometabólicas en la enfermedad pulmonar obstructiva crónica. Nutr Hosp. 2013;28(4):1022-1030 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318 | eng |
dcterms.references | Calverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P et al. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007; 356: 775-89. | eng |
dcterms.references | Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R, ECLIPSE Investigators: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31(4):869–873. | eng |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 368 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: